Item request has been placed!
×
Item request cannot be made.
×
Processing Request
Study offering new hope for medical presbyopia correction.
Item request has been placed!
×
Item request cannot be made.
×
Processing Request
- Author(s): Yeu, Elizabeth1
- Source:
Ophthalmology Times. Oct2023, Vol. 48 Issue 10, p38-40. 2p.
- Subject Terms:
- Additional Information
- Abstract:
The article presents results of the BRIO-I study, a clinical trial of Brimochol PF, a topical fixed-dose combination for the treatment of presbyopia from Visus Therapeutics, which references a research paper by R. S. Verhoeven et al., published in a 2022 issue of the "Investigative Ophthalmology & Visual Science." It discusses a comparison of a single dose of the drug with individual monotherapies, and the implications of the study for future medical presbyopia correction.
No Comments.